Fannin Innovation Studio
Houston, Texasfannininnovation.com
Overview
Fannin Innovation Studio is a Houston-based venture capital firm and life science venture studio that commercializes early-stage therapeutic, medical device, and diagnostic technologies by in-licensing assets from academic institutions and developing them internally.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Goldenrod Therapeutics, Inc. | Jun 2026 | Seed | Lead |
| Pulmotect | Sep 2024 | Series C | Lead |
| Procyrion | Feb 2024 | Series E | Lead |
| Allterum Therapeutics | Dec 2020 | Seed | - |
| Procyrion | Jul 2019 | Series D | Co-investor |
Key People
Michael Heffernan
Director of Research & Technology
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
